| Resistance status |
New cases (n=165) n (%) |
Re-treated cases (n=65) n (%) |
Total (n=230) n (%) |
| Any resistance |
39(23.6) |
38(58.5) |
77(33.5) |
| Multidrug resistance |
3(1.8) |
12(18.5) |
15(6.5) |
| HR |
1(0.6) |
- |
1(0.4) |
| HSR |
1(0.6) |
3(4.6) |
4(1.7) |
| HSRE |
1(0.6) |
9(13.9) |
10(4.4) |
| Resistance to 1 drug only |
22(13.3) |
18(27.7) |
40(17.4) |
| H |
7(4.2) |
5(7.7) |
12(5.2) |
| S |
14(8.5) |
12(18.5) |
26(11.3) |
| R |
1(0.6) |
1(1.5) |
2(0.9) |
| E |
- |
- |
- |
| Resistance to 2 drugs |
13(7.9) |
7(10.8) |
20(8.7) |
| HS |
7(4.2) |
4(6.2) |
11(4.8) |
| SR |
4(2.4) |
2(3.1) |
6(2.6) |
| SE |
1(0.6) |
1(1.5) |
2(0.9) |
| HR |
1(0.6) |
- |
1(0.4) |
| Resistance to 3 drugs |
3(1.8) |
4(6.2) |
7(3.0) |
| HSE |
2(0.12) |
1(1.5) |
3(1.3) |
| HSR |
1(0.6) |
3(4.6) |
4(1.7) |
| Resistance to all drugs |
1(0.6) |
9(13.9) |
10(4.4) |
Key: H-Isoniazid, S- Streptomycin, R- Rifampicin , E-Ethambutol, MDR- TB -resistance to at least Isoniazid and Rifampicin , “_”: indicates absence of resistance |
